System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Bruno Annibale is an expert in Gastroenterology at Azienda Ospedaliera Sant'Andrea (Italy). As of October 2026, ScienceLeadR ranks Bruno Annibale in the top 1% of experts worldwide for Gastritis and Iron Deficiencies. Bruno Annibale has authored 527 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 1,771 (community average: 125). How the SLR is computed.

LeadR Profile

Bruno Annibale Azienda Ospedaliera Sant'Andrea Italy
1 771 ScienceLeadR Reputation 1771

Unlock

Register Login
Network Map

Gastroenterology

Subspecialties: Medical Imaging - Hepatology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 527

Citations

Citations: 15 957 1st author: 41 Last author: 182 Unique author: 1

Main journals

Dig Liver Dis 139
Endoscopy 35
Aliment Pharmacol Ther 33
Gastroenterology 29
Neuroendocrinology 12

Best Journals

Ann Oncol 2
Lancet 2
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Management Strategies and Outcomes for Type 1 Gastric Neuroendocrine Tumors Measuring More Than 1 cm.
PMID 42607265 — gastroenterology, progression-free survival, neoplasms, neuroendocrine tumors, wounds and injuries, endoscopic mucosal resection		Clin Transl Gastroenterol20260
Reassessment of non-visible non-invasive neoplasia on gastric mucosa: Case series from a referral centre.
PMID 42498559 — neoplasms, biopsy, endoscopy, gastric mucosa, mucous membrane		Arab J Gastroenterol20260
Helicobacter pylori-specific genes in gastric biopsies of patients with autoimmune gastritis with and without gastric cancer.
PMID 42472061 — genes, helicobacter pylori, helicobacter, neoplasms, biopsy, gastritis, tissues, stomach neoplasms		J Transl Autoimmun20260
Efficacy, Safety, and Hematologic Recovery Following Intravenous Ferric Carboxymaltose in Patients with Iron Malabsorption-Related Iron Deficiency Anemia: A Prospective Clinical Study.
PMID 42280452 — safety, anemia, transferrin, anemia, iron-deficiency, recycling, aftercare, food, ferritins, therapeutics, celiac disease, iron deficiencies		Nutrients20260
Poliprotect in the PPI Deprescription Phase of Endoscopy-Negative Heartburn and Epigastric Pain Syndrome Patients: An RCT Post Hoc Analysis.
PMID 42226497 — quality of life, pain, heartburn, signs and symptoms, deprescriptions, endoscopy, omeprazole, non-responder		Neurogastroenterol Motil20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 5
N/A 2
Phase 4 1

By status:

Unknown 3
Recruiting 2
Completed 1
Not yet recruiting 1
Terminated 1

By type:

Interventional 6
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to evaluate safety and explore efficacy of new lipase NHS7108 compared with pancrelipase in adult participants with exocrine pancreatic insufficiency
2025-521816-20-00 — exocrine pancreatic insufficiency, lipase, safety, cross-over studies, pancrelipase		Phase 2Not yet recruiting2026
Study that aims to investigate how effective and safe the use of a novel modified release tablet formulation of Colesevelam hydrochloride MMX is for patients with bile acid diarrhoea (BAD) randomly allocated to 2 different dose regimens of the active product or to the inactive placebo formulation
2024-511993-55-00 — bile, safety, colesevelam hydrochloride, tablets		Phase 2Recruiting2025
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency
NCT07559175 — escherichia, exocrine pancreatic insufficiency, lipase, safety, fibrosis, pharmaceutical preparations, amylases, cross-over studies, pancrelipase, bacillus, diet, capsules, cystic fibrosis, enzymes, escherichia coli, peptide hydrolases, therapeutics, meals, bacteria, triglycerides, snacks, absorption, pancreatic diseases		Phase 2Recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS